trending Market Intelligence /marketintelligence/en/news-insights/trending/xrvxb_hvpiegoy_8w76bta2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

US FTC conditionally approves Abbott's $25B acquisition of St. Jude Medical

Brazil Pay TV Down Record Amount In 2019, With Losses Continuing In Q1'20

Impact of COVID 19 on US Video Entertainment Trends

Case Study: Transforming Sales Enablement Data at a Global Advertising and Media Firm

Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19

US FTC conditionally approves Abbott's $25B acquisition of St. Jude Medical

The U.S. Federal Trade Commission conditionally approved Abbott Laboratories' proposed acquisition of fellow competitor St. Jude Medical Inc. in a deal valued at $25 billion.

Abbott is required to sell its steerable sheath business to Terumo Corp., while St. Jude will off-load its vascular closure device business to the Tokyo-based medical device maker to appease the regulator's anti-competitive concerns.

The companies agreed in principle to sell the businesses to Terumo for $1.12 billion in October.

Vascular closure devices are used to close holes made in an artery and prevent bleeding. Steerable sheaths are used to help position catheters into the heart.